New theory on cause of endometriosis

March 07, 2014

Changes to two previously unstudied genes are the centerpiece of a new theory regarding the cause and development of endometriosis, a chronic and painful disease affecting 1 in 10 women.

The discovery by Northwestern Medicine scientists suggests epigenetic modification, a process that enhances or disrupts how DNA is read, is an integral component of the disease and its progression. Matthew Dyson, research assistant professor of obstetrics and gynecology at Northwestern University Feinberg School of Medicine and and Serdar Bulun, MD, chair of obstetrics and gynecology at Feinberg and Northwestern Memorial Hospital, also identified a novel role for a family of key gene regulators in the uterus.

"Until now, the scientific community was looking for a genetic mutation to explain endometriosis," said Bulun, a member of the Center for Genetic Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. "This is the first conclusive demonstration that the disease develops as a result of alterations in the epigenetic landscape and not from classical genetic mutations."

The findings were recently published in PLoS Genetics.

Women develop endometriosis when cells from the lining of the uterus, usually shed during menstruation, grow in other areas of the body. The persistent survival of these cells results in chronic pelvic pain and infertility. Although the cause of the disease has remained unknown on a cellular level, there have been several different models established to explain its development.

Endometriosis only occurs in menstruating primates, suggesting that the unique evolution behind uterine development and menstruation are linked to the disease. Scientists consider retrograde menstruation - cells moving up the fallopian tubes and into the pelvis - as one probable cause. Previous models, however, have been unable to explain why only 10 percent of women develop the disease when most experience retrograde menstruation at some point. Nor do they explain instances of endometriosis that arise independent of menstruation.

Bulun and Dyson propose that an epigenetic switch permits the expression of the genetic receptor GATA6 rather than GATA2, resulting in progesterone resistance and disease development.

"We believe an overwhelming number of these altered cells reach the lining of the abdominal cavity, survive and grow," Bulun said. "These findings could someday lead to the first noninvasive test for endometriosis."

Clinicians could then prevent the disease by placing teenagers predisposed to this epigenetic change on a birth control pill regimen, preventing the possibility of retrograde menstruation in the first place, Bulun said.

Dyson will also look to use the epigenetic fingerprint resulting from the presence of GATA6 rather than GATA2 as a potential diagnostic tool, since these epigenetic differences are readily detectable.

"These findings have the potential to shift how we view and treat the disease moving forward," Bulun said.
-end-
The project was supported by grant R37-HD38691from the National Institute Child Health and Human Development of the National Institutes of Health and a grant from the Friends of Prentice.

Northwestern University

Related Endometriosis Articles from Brightsurf:

Scientists discover possible genetic target for treating endometriosis
Michigan State University researchers have identified a potential genetic target for treating an especially painful and invasive form of endometriosis.

RUDN University doctors suggested ways to reduce obstetrical complications in endometriosis patients
A team of doctors from RUDN University with their Italian colleagues had studied the data of existing studies on the effect of endometriosis on pregnancy and childbirth and suggested ways to reduce obstetrical complications in women with this condition.

Endometriosis: No cure, but diagnosis could avert surgery
Jasmin Teurlings is one of 176 million women worldwide who have endometriosis, a chronic, painful gynaecological condition that affects nearly three times as many women as breast cancer.

NIH-funded study links endometriosis to DNA changes
DNA from uterine cells of women with endometriosis has different chemical modifications, compared to the DNA of women who do not have the condition, according to researchers funded by the National Institutes of Health.

Researchers use nanotechnology to develop new treatment for endometriosis
Scientists have developed a precise, nanotechnology-based treatment to alleviate the pain and fertility problems associated with endometriosis, a common gynecological condition in women of childbearing age.

Cannabinoids improve symptoms in mice with endometriosis
Initial results from treating endometriosis in mice with cannabinoids suggest they can alleviate some symptoms of the disease, according to a new study in the open-access journal eLife.

Endometriosis could be treated with cancer drug, study suggests
The painful symptoms of endometriosis -- a chronic condition which affects millions of women -- could potentially be reduced with a drug that had previously been investigated as a cancer treatment.

Australian women turning to cannabis to treat endometriosis symptoms
A new study published today in Journal of Obstetrics Gynaecology Canada has found one in eight Australian women with endometriosis use cannabis to alleviate pain and other symptoms, rating the plant based medicine as the most effective way to self-manage the disorder.

Endometriosis may be costing us much more than previously thought
Along with significant physical pain, endometriosis also hurts Australian women at the hip pocket, as well as having significant economic effects on society as a whole, a new study published today in PLOS ONE confirms.

Endometrial diseases can be imitated in a lab dish, new study shows
Biomedical researchers at KU Leuven have found a new way to study endometrial diseases such as endometriosis and cancer.

Read More: Endometriosis News and Endometriosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.
Can't connect to localhost. Errorcode: 1203